Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis

PaperCitations, authors & open-access status

The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 47 citations, 2020 year and gold oa status.

47
Citations
2020
Year
gold
OA Status

Related on ScholarIQ

Nannan Du
Author
World Journal of Surgical Oncology
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
CAR-T cell therapy research
Topic
Immunotherapy and Immune Responses
Topic
470M+ articles · free account